Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

Similar articles for PubMed (Select 16708368)

1.

Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial.

Bird SJ, Brown MJ, Spino C, Watling S, Foyt HL.

Muscle Nerve. 2006 Aug;34(2):214-24.

PMID:
16708368
2.

Natural progression of diabetic peripheral neuropathy in the Zenarestat study population.

Brown MJ, Bird SJ, Watling S, Kaleta H, Hayes L, Eckert S, Foyt HL; Zenarest study.

Diabetes Care. 2004 May;27(5):1153-9.

PMID:
15111537
3.
4.

Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects.

Gelber DA, Pfeifer MA, Broadstone VL, Munster EW, Peterson M, Arezzo JC, Shamoon H, Zeidler A, Clements R, Greene DA, et al.

J Diabetes Complications. 1995 Jul-Sep;9(3):170-6.

PMID:
7548981
5.

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.

Hotta N, Akanuma Y, Kawamori R, Matsuoka K, Oka Y, Shichiri M, Toyota T, Nakashima M, Yoshimura I, Sakamoto N, Shigeta Y.

Diabetes Care. 2006 Jul;29(7):1538-44.

PMID:
16801576
6.
7.

Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes.

Kincaid JC, Price KL, Jimenez MC, Skljarevski V.

Muscle Nerve. 2007 Dec;36(6):821-7.

PMID:
17683081
8.

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group.

Greene DA, Arezzo JC, Brown MB.

Neurology. 1999 Aug 11;53(3):580-91. Erratum in: Neurology 2001 Apr 24;56(8):1124.

PMID:
10449124
9.

Quantitative sensory testing.

Siao P, Cros DP.

Phys Med Rehabil Clin N Am. 2003 May;14(2):261-86. Review.

PMID:
12795516
10.

[Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement].

Shimada H, Miki T, Kyogoku I, Kawagishi T, Inaba M, Okuno Y, Nishizawa Y, Morii H.

No To Shinkei. 1998 Sep;50(9):817-20. Japanese.

PMID:
9789304
11.

Sensory testing versus nerve conduction velocity in diabetic polyneuropathy.

Redmond JM, McKenna MJ, Feingold M, Ahmad BK.

Muscle Nerve. 1992 Dec;15(12):1334-9.

PMID:
1470197
12.

A 12-month randomized controlled study of the aldose reductase inhibitor ponalrestat in patients with chronic symptomatic diabetic neuropathy.

Krentz AJ, Honigsberger L, Ellis SH, Hardman M, Nattrass M.

Diabet Med. 1992 Jun;9(5):463-8.

PMID:
1611835
13.

The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats.

Shimoshige Y, Ikuma K, Yamamoto T, Takakura S, Kawamura I, Seki J, Mutoh S, Goto T.

Metabolism. 2000 Nov;49(11):1395-9.

PMID:
11092500
15.

Aldose reductase inhibition alters nodal Na+ currents and nerve conduction in human diabetics.

Misawa S, Kuwabara S, Kanai K, Tamura N, Nakata M, Sawai S, Yagui K, Hattori T.

Neurology. 2006 May 23;66(10):1545-9.

PMID:
16717216
16.

Methods for assessing diabetic polyneuropathy: validity and reproducibility of the measurement of sensory symptom severity and nerve function tests.

Valk GD, Grootenhuis PA, van Eijk JT, Bouter LM, Bertelsmann FW.

Diabetes Res Clin Pract. 2000 Feb;47(2):87-95.

PMID:
10670907
17.
18.

A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group.

Macleod AF, Boulton AJ, Owens DR, Van Rooy P, Van Gerven JM, Macrury S, Scarpello JH, Segers O, Heller SR, Van Der Veen EA.

Diabete Metab. 1992 Jan-Feb;18(1):14-20.

PMID:
1563531
19.

Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy.

Florkowski CM, Rowe BR, Nightingale S, Harvey TC, Barnett AH.

Diabetes. 1991 Jan;40(1):129-33.

PMID:
1901808
20.

Quantitative thermal sensory testing in patients with amyotrophic lateral sclerosis using reaction time exclusive method of levels (MLE).

Deepika J, Manvir B, Sumit S, Vinay G, Trilochan S, Garima S, Padma MV, Madhuri B.

Electromyogr Clin Neurophysiol. 2006 May-Jun;46(3):145-8.

PMID:
16918198
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk